Novabay Pharmaceuticals Inc
Research Novabay Pharmaceuticals Inc (NBY) on Bullrun: market cap USD 40.23M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNBY
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 40.23M
- Financial periodFY2025
- RevenueUSD 0
- Net income-USD 22.14M
- Free cash flow-USD 8.43M
Valuation Snapshot
latest market cap is USD 40.23M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 22.14M | -USD 8.43M | n/a | -19 | USD 7.96M | USD 776.00K | -USD 23.18M |
| FY2024 | USD 0 | -USD 7.22M | -USD 7.50M | n/a | -12.68 | USD 430.00K | USD 1.67M | -USD 129.00K |
| FY2023 | USD 10.46M | -USD 9.64M | -USD 4.28M | 58.2% | -695.7 | USD 2.92M | USD 2.61M | USD 3.31M |
| FY2022 | USD 14.40M | -USD 10.61M | -USD 6.77M | 54.0% | -1767.5 | USD 5.36M | USD 2.04M | USD 10.55M |
| FY2021 | USD 10.20M | -USD 5.82M | -USD 9.24M | 63.8% | -920.5 | USD 7.50M | USD 551.00K | USD 10.17M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-04-17 | USD 40.23M | n/a | 259.7% | 4 |
| 2025 | 2025-12-31 | USD 710.70M | n/a | 14.2% | 4 |
| 2024 | 2024-12-31 | USD 2.93M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.31M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.65M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 18.15M | n/a | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 4 USD.
| Year | Dividends/share |
|---|---|
| FY2025 | 4 USD |
About Novabay Pharmaceuticals Inc
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Novabay Pharmaceuticals Inc's market cap?
Novabay Pharmaceuticals Inc's market capitalization is USD 40.23M.
What does Novabay Pharmaceuticals Inc do?
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc.